Back
Syros Pharmaceuticals Vs. Entrada Therapeutics Industry Stock Comparison
Sell
36
SYRS
Syros Pharmaceuticals
Last Price:
1.98
Seasonality Move:
-18.92%
Sell
37
TRDA
Entrada Therapeutics
Last Price:
14.98
Seasonality Move:
13.84%
Sell
36
Syros Pharmaceuticals (SYRS)
is a Sell
Is Syros Pharmaceuticals a Buy, Sell or Hold?
- The current Syros Pharmaceuticals [SYRS] share price is $1.98. The Score for SYRS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SYRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $13.66. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYRS Stock Price Chart
What is Syros Pharmaceuticals's stock price today?
-
The Syros Pharmaceuticals share price today is $1.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing slight selling pressure.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $13.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.
SYRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.41 | Sell |
Relative Strength Index (14 RSI): | 40.41 | Sell |
Chaikin Money Flow: | -47118 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.51 - 1.81) | Buy |
Bollinger Bands (100): | (2.78 - 6.2) | Sell |
TRDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 34.17 | Sell |
Chaikin Money Flow: | -107441 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.74 - 16.8) | Sell |
Bollinger Bands (100): | (14.08 - 16.6) | Sell |
SYRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.76 | Buy |
20-day SMA: | 1.67 | Buy |
50-day SMA: | 3.67 | Sell |
200-day SMA: | 5.34 | Sell |
8-day EMA: | 1.83 | Buy |
20-day EMA: | 2.01 | Sell |
50-day EMA: | 3.07 | Sell |
200-day EMA: | 4.58 | Sell |
TRDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.6 | Sell |
20-day SMA: | 15.61 | Sell |
50-day SMA: | 15.96 | Sell |
200-day SMA: | 14.67 | Sell |
8-day EMA: | 14.57 | Sell |
20-day EMA: | 15.2 | Sell |
50-day EMA: | 15.49 | Sell |
200-day EMA: | 14.99 | Sell |
Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.12 per share, an increase this year of $2.67 per share, and a decrease next year of $0.64 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Syros Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Entrada Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |